|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Conceptus, Inc. (CPTS) Announces That Hologic, Inc. (HOLX)'s Motion for New Trial in Patent Infringement Case is Denied
1/10/2012 9:47:23 AM
MOUNTAIN VIEW, Calif., Jan. 9, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS),developer of the Essure® procedure, the leading non-surgical permanent birth control method, announced today that Judge William Alsup of the United States District Court, Northern District of California, denied Hologic Inc.'s motions seeking to overturn the jury's verdict that the use of Hologic's Adiana System infringed on Conceptus' patent rights. While the court denied the Conceptus motion for permanent injunction, which sought to permanently enjoin Hologic from selling its Adiana system in the United States and denied Conceptus' request for supplemental damages, it specifically noted that Conceptus is entitled to file a supplemental complaint seeking damages since June 30, 2011.
|
|
|
|
|
|
|
|
|
|
|